glp-1 hub podcast Ana Reisdorf, MS, RD - Founder of Hub, advancing evidence-based GLP-1 knowledge across podcast, video, and online communities From Injections to Pills: Breaking

In terms of body weight, oral-semaglutide treatment led to mean reductions of -2.5 kg (treatment-policy estimand) and -2.7 kg (trial-product estimand)

it depends on modifying the biological feedback systems that regulate hunger, energy balance, and fat storage

Show Sources SOURCES: Photo Credit: iStock/Getty Images StatPearls [Internet] : "Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)." Diabetes, Obesity, and Metabolism : "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Society of Behavioral Medicine: "What are GLP-1 Medications

[10] [11] Beyond weight reduction , GLP-1 receptor agonists may offer additional metabolic benefits

When an Integrative Approach Makes Sense There are situations where GLP-1 medications are medically necessary, particularly in advanced type 2 diabetes or severe metabolic disease

Viking Therapeutics Inc